MYC and head and neck squamous cell carcinoma: As EZH2 can regulate MYC expression at the transcriptional level or promote MYC stabilization as a non‐PRC2 partner in several tumors,[9, 13] this prompted us to examine whether squamocin treatment also affected EZH2 levels in two HNSCC cell lines.